Characterization of Thermophilic Novel-Rare Actinobacteria from Hot Springs and Compost as an Unique Secondary Metabolite Producer

Ruhul Maghfirah, Pati Kemala, Syarifah Yanti Astryna

Abstract


This review aims to explain in more detail about the Actinobacteria and it secondary metabolites. Some species of Actinobacteria can live in extreme environments such as high acid, high base, high salt and even high temperatures. Actinobacteria mainly of the genus Streptomyces sp. has been known to produce bioactive compounds such as antibacterial, antifungal, anticancer, antitumor, anticytotoxic, anti-inflammatory, anti-parasitic, anti-malarial, antiviral and antioxidant. This study reviews various research findings on Actinobacteria species and their ability to thrive in extreme environments. It also reviews the findings of bioactive compounds isolated from Actinobacteria and their potential applications. Some species in the genera Streptomyces, Thermonospora, and Thermoactinomyces have optimal growth temperatures above 55°C and are categorized as thermophilic. More than 30,000 bioactive compounds that have been isolated are derived from Actinobacteria and 80% are from the genus Streptomyces sp. Benzastatin C and 3-Chloro-Tetrahidroquinolon are new antivirals isolated from Streptomyces nitrosporeus. Essramycin is a novel antibiotic that shows activity against Gram positive and Gram negative bacteria. Chandrananimycin A isolated from Actinomadura sp. and N-(2-hydroxyphenyl)-2-Phenazinamin (NHP) isolated from Nocardia dassonvillei are novel antibiotics that can be used as antifungals, antialgas, antibacterials and anticancer. The potential of Actinobacteria in producing bioactive compounds can advance the field of science and technology in the future and become an alternative to overcome the problem of resistance to pathogenic microorganisms are increasing.


Full Text:

PDF

References


D. A. Hopwood, “Streptomyces genes: From Waksman to Sanger,” in Journal of Industrial Microbiology and Biotechnology, 2003, doi: 10.1007/s10295-003-0031-7.

R. Araujo-Melo, I. Souza, M. Vicalvi-Costa, J. Araújo, K. Sena, and L. Coelho, “Actinobacteria: Versatile Microorganisms with Medical and Pharmaceutical Application,” Br. Biotechnol. J., 2016, doi: 10.9734/bbj/2016/28728.

D. V Chavan, S. S. Mulaje, and R. Y. Mohalkar, “A Review on actinomycetes and their biotechnological applications,” Int. J. Pharm. Sci. Res., 2013.

L. Shivlata and T. Satyanarayana, “Thermophilic and alkaliphilic Actinobacteria: Biology and potential applications,” Frontiers in Microbiology. 2015, doi: 10.3389/fmicb.2015.01014.

I. S., R. J., S. S. N., S. K., T. T., and K. L., “Isolation of two thermophilic actinobacterial strains mud volcano of the Baratang Island, India,” African J. Microbiol. Res., 2014, doi: 10.5897/ajmr09.126.

a Gousterova, D. Paskaleva, and E. Vasileva-Tonkova, “Characterization of culturable thermophilic actinobacteria from Livingston Island, Antarctica,” Int. Res. J. Biol. Sci., 2014.

R. Anandan, D. Dharumadurai, and G. P. Manogaran, “An Introduction to Actinobacteria. In Actinobacteria,” Basics Biotechnol. Appl., 2016.

B. Pandey, P. Ghimire, and V. P. Agrawal, “Studies on the antibacterial activity of the Actinomycetes isolated from the Khumbu Region of Nepal,” J. Biol. Sci, , 2004.

M. P. Lechevalier, H. Prauser, D. P. Labeda, and J. S. Ruan, “Two new genera of nocardioform actinomycetes: Amycolata gen. nov. and Amycolatopsis gen. nov.,” Int. J. Syst. Bacteriol., 1986, doi: 10.1099/00207713-36-1-29.

M. Chandrasekaran, “Industrial enzymes from marine microorganisms: The Indian scenario,” J. Mar. Biotechnol., 1997.

E. A. Barka et al., “Taxonomy, Physiology, and Natural Products of Actinobacteria,” Microbiol. Mol. Biol. Rev., 2016, doi: 10.1128/mmbr.00019-15.

M. P. Lechevalier and H. A. Lechevalier, “Actinoplanete with cylindrical sporangia, Actinoplanes rectilineatus sp.nov.,” Int. J. Syst. Bacteriol., 1975, doi: 10.1099/00207713-25-4-371.

M. Takizawa, R. R. Colwell, and R. T. Hill, “Isolation and diversity of actinomycetes in the Chesapeake Bay,” Appl. Environ. Microbiol., 1993, doi: 10.1128/aem.59.4.997-1002.1993.

R. E. de Lima Procópio, I. R. da Silva, M. K. Martins, J. L. de Azevedo, and J. M. de Araújo, “Antibiotics produced by Streptomyces,” Brazilian Journal of Infectious Diseases. 2012, doi: 10.1016/j.bjid.2012.08.014.

M. Sharma, “Actinomycetes: Source, Identification, and Their Applications,” Int. J. Curr. Microbiol. Appl. Sci., 2014.

A. Hasani, A. Kariminik, and K. Isaazadeh, “Streptomycetes : Characteristics and Their Antimicrobial Activities,” Int. J. Adv. Biol. Biomed. Res., 2014.

T. Hasegawa, S. Tanida, and H. Ono, “Thermomonospora formosensis sp. nov.,” Int. J. Syst. Bacteriol., 1986, doi: 10.1099/00207713-36-1-20.

S. K. Agadagba et al., “Isolation of Actinomycetes from Soil,” J. Microbiol. Res., 2014.

J. Lacey, “Actinomycetes in composts,” Annals of Agriculture and Environmental Medicine. 1997.

G. Cuesta, R. García-de-la-Fuente, M. Abad, and F. Fornes, “Isolation and identification of actinomycetes from a compost-amended soil with potential as biocontrol agents,” J. Environ. Manage., 2012, doi: 10.1016/j.jenvman.2010.11.023.

A. Soler, J. García-Hernández, A. Zornoza, and J. L. Alonso, “Diversity of culturable nocardioform actinomycetes from wastewater treatment plants in Spain and their role in the biodegradability of aromatic compounds,” Environ. Technol. (United Kingdom), 2018, doi: 10.1080/09593330.2017.1296897.

B. L. Nguyen and A. T. P. Hoang, “Screening of cellulolytic actinomycetes for decomposition of agricultural waste,” Chem. Eng. Trans., 2020, doi: 10.3303/CET2078048.

T. Stalin, “Ecofriendly application of cellulase and xylanase producing marine Streptomyces clavuligerus as enhancer in biogas production from waste,” African J. Environ. Sci. Technol., 2012, doi: 10.5897/ajest12.034.

D. Dhakal, A. R. Pokhrel, B. Shrestha, and J. K. Sohng, “Marine rare actinobacteria: Isolation, characterization, and strategies for harnessing bioactive compounds,” Frontiers in Microbiology. 2017, doi: 10.3389/fmicb.2017.01106.

T. M. Iqbalsyah, C. Nisak, F. Sartika, N. Saidi, and F. Febriani, “Identification of Antibiotic in Ethyl Acetate Fraction Produced by A Local Isolate PLS 80 Isolated from Shallow Sea Fumaroles,” in IOP Conference Series: Earth and Environmental Science, 2019, doi: 10.1088/1755-1315/276/1/012006.

. F., N. H. Ulwiyyah, N. Saidi, and T. M. Iqbalsyah, “Screening and Production of Lipase from a Thermo-halophilic Bacterial Isolate of Pria Laot Sabang 80 Isolated from Under Water Hot Spring,” KnE Eng., vol. 1, no. 2, p. 105, 2019, doi: 10.18502/keg.v1i2.4436.

D. De Simeis and S. Serra, “Actinomycetes: A never-ending source of bioactive compounds—an overview on antibiotics production,” Antibiotics, vol. 10, no. 5, 2021, doi: 10.3390/antibiotics10050483.

M. S. M. Selim, S. A. Abdelhamid, and S. S. Mohamed, “Secondary metabolites and biodiversity of actinomycetes,” J. Genet. Eng. Biotechnol., vol. 19, no. 1, p. 72, 2021, doi: 10.1186/s43141-021-00156-9.

M. S. Abdelfattah, M. I. Y. Elmallah, U. W. Hawas, L. A. El-Kassem, and A. H. El-Desoky, “Isolation and characterization of marine-derived actinomycetes with cytotoxic activity from the Red Sea coast,” Asian Pac. J. Trop. Biomed., 2016, doi: 10.1016/j.apjtb.2016.06.004.

P. Manivasagan, J. Venkatesan, K. Sivakumar, and S. K. Kim, “Pharmaceutically active secondary metabolites of marine actinobacteria,” Microbiological Research. 2014, doi: 10.1016/j.micres.2013.07.014.

H. A. D. Ruwandeepika, G. C. P. Fernando, and T. S. P. Jayaweera, “An overview of biomedical, biotechnological, and industrial applications of actinomycetes,” in Natural Products from Actinomycetes: Diversity, Ecology and Drug Discovery, 2022.

W. A Elkhateeb, “Marine Actinomycetes the Past, the Present and the Future,” Open Access J. Pharm. Res., 2021, doi: 10.23880/oajpr-16000241.

C. Oldfield, N. T. Wood, S. C. Gilbert, F. D. Murray, and F. R. Faure, “Desulphurisation of benzothiophene and dibenzothiophene by actinomycete organisms belonging to the genus Rhodococcus, and related taxa,” Antonie van Leeuwenhoek, Int. J. Gen. Mol. Microbiol., 1998, doi: 10.1023/A:1001724516342.

J. Mann, “Natural products as immunosuppressive agents,” Natural Product Reports. 2001, doi: 10.1039/b001720p.

J. Bérdy, “Bioactive microbial metabolites: A personal view,” Journal of Antibiotics. 2005, doi: 10.1038/ja.2005.1.

W. Yang, Y. He, L. Xu, H. Zhang, and Y. Yan, “A new extracellular thermo-solvent-stable lipase from Burkholderia ubonensis SL-4: Identification, characterization and application for biodiesel production,” J. Mol. Catal. B Enzym., vol. 126, pp. 76–89, 2016, doi: 10.1016/j.molcatb.2016.02.005.

S. D. Bentley et al., “Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2),” Nature, 2002, doi: 10.1038/417141a.

K. S. Lam, “Discovery of novel metabolites from marine actinomycetes,” Current Opinion in Microbiology. 2006, doi: 10.1016/j.mib.2006.03.004.

A. Kelecom, “Secondary metabolites from marine microorganisms,” An. Acad. Bras. Cienc., 2002, doi: 10.1590/S0001-37652002000100012.

P. Habbu, V. Warad, R. Shastri, S. Madagundi, and V. H. Kulkarni, “Antimicrobial metabolites from marine microorganisms,” Chinese Journal of Natural Medicines . 2016, doi: 10.1016/S1875-5364(16)60003-1.

J. M. Raaijmakers, M. Vlami, and J. T. de Souza, “Antibiotic production by bacterial biocontrol agents,” Antonie van Leeuwenhoek, Int. J. Gen. Mol. Microbiol., 2002, doi: 10.1023/A:1020501420831.

S. Ravikumar, N. Thajuddin, P. Suganthi, S. Jacob Lnbaneson, and T. Vinodkumar, “Bioactive potential of seagrass bacteria against human bacterial pathogens,” J. Environ. Biol., 2010.

M. Raja, S. Ravikumar, M. Gnanadesigan, and V. Vijayakumar, “In vitro antibacterial activity of diterpene and benzoxazole derivatives from Excoecaria agallocha L.,” Int. J. Biol. Chem. Sci., 2010, doi: 10.4314/ijbcs.v4i3.60494.

B. El Amraoui, M. El Amraoui, N. Cohen, and A. Fassouane, “Antifungal and antibacterial activity of marine microorganisms,” Ann. Pharm. Fr., 2014, doi: 10.1016/j.pharma.2013.12.001.

A. S. Chaudhary, “A review of global initiatives to fight antibiotic resistance and recent antibiotics׳ discovery,” Acta Pharm. Sin. B, 2016, doi: 10.1016/j.apsb.2016.06.004.

J. P. Robinson, “Microbiological Applications,” Curr. Protoc. Cytom., 2010, doi: 10.1002/0471142956.cy1100s52.

R. H. Baltz, “Daptomycin: mechanisms of action and resistance, and biosynthetic engineering,” Current Opinion in Chemical Biology. 2009, doi: 10.1016/j.cbpa.2009.02.031.

H. Mohamed, B. Miloud, F. Zohra, J. M. García-Arenzana, A. Veloso, and S. Rodríguez-Couto, “Isolation and Characterization of Actinobacteria from Algerian Sahara Soils with Antimicrobial Activities,” Int. J. Mol. Cell. Med., 2017, doi: 10.22088/ACADPUB.BUMS.6.2.5.

A. A. Elbendary et al., “Isolation of antimicrobial producing Actinobacteria from soil samples,” Saudi J. Biol. Sci., 2018, doi: 10.1016/j.sjbs.2017.05.003.

M. M. A. El-Gendy, M. Shaaban, K. A. Shaaban, A. M. El-Bondkly, and H. Laatsch, “Essramycin: A first triazolopyrimidine antibiotic isolated from nature,” J. Antibiot. (Tokyo)., 2008, doi: 10.1038/ja.2008.124.

S. Ramesh and N. Mathivanan, “Screening of marine actinomycetes isolated from the Bay of Bengal, India for antimicrobial activity and industrial enzymes,” World J. Microbiol. Biotechnol., 2009, doi: 10.1007/s11274-009-0113-4.

G. Gebreyohannes, F. Moges, S. Sahile, and N. Raja, “Isolation and characterization of potential antibiotic producing actinomycetes from water and sediments of Lake Tana, Ethiopia,” Asian Pac. J. Trop. Biomed., 2013, doi: 10.1016/S2221-1691(13)60092-1.

A. Bharti, V. Kumar, O. Gusain, and G. S. Bisht, “Antifungal Activity of Actinomycetes Isolated from Garhwal Region,” J. Sci. Engglish Technol., 2010.

W. Muiru, E. Mutitu, and D. Mukunya, “Characterization of antibiotic metabolites from actinomycete isolates,” African Crop Sci. Conf. Proc., 2007.

M. Gupte, P. Kulkarni, and B. N. Ganguli, “Antifungal antibiotics,” Applied Microbiology and Biotechnology. 2002, doi: 10.1007/s002530100822.

P. K. Jain and P. C. Jain, “Antifungal activity of some actinomycetes isolated from various habitats.,” Hindustan Antibiot. Bull., 2003.

E. I. Rabea, M. E. T. Badawy, C. V. Stevens, G. Smagghe, and W. Steurbaut, “Chitosan as antimicrobial agent: Applications and mode of action,” Biomacromolecules. 2003, doi: 10.1021/bm034130m.

C. C. Lin and H. L. Lin, “Remediation of soil contaminated with the heavy metal (Cd2+),” J. Hazard. Mater., 2005, doi: 10.1016/j.jhazmat.2005.02.017.

C. Shi, Y. Zhu, X. Ran, M. Wang, Y. Su, and T. Cheng, “Therapeutic Potential of Chitosan and Its Derivatives in Regenerative Medicine,” J. Surg. Res., 2006, doi: 10.1016/j.jss.2005.12.013.

M. J. Swift, R. M. Atlas, and R. Bartha, “Microbial Ecology: Fundamentals and Applications.,” J. Ecol., 1982, doi: 10.2307/2259932.

G. Bacteria, “Supragingival Microbes,” Atlas Oral Microbiol., pp. 41–65, 2015, doi: 10.1016/b978-0-12-802234-4.00003-3.

R. P. Maskey et al., “Marine Bacteria. Part 28. Anticancer and Antibacterial Trioxacarcins with High Antimalaria Activity from a Marine Streptomycete and Their Absolute Stereochemistry,” ChemInform, 2005, doi: 10.1002/chin.200525213.

X. Gao et al., “A novel anticancer and antifungus phenazine derivative from a marine actinomycete BM-17,” Microbiol. Res., 2012, doi: 10.1016/j.micres.2012.02.008.

Y. Han, B. Yang, F. Zhang, X. Miao, and Z. Li, “Characterization of antifungal chitinase from marine Streptomyces sp. DA11 associated with South China sea sponge Craniella australiensis,” Mar. Biotechnol., 2009, doi: 10.1007/s10126-008-9126-5.

A. K. Shukla, B. K. Singh, S. Patra, and V. K. Dubey, “Rational approaches for drug designing against leishmaniasis,” Appl. Biochem. Biotechnol., 2010, doi: 10.1007/s12010-009-8764-z.

J. P. Gillet, T. Efferth, and J. Remacle, “Chemotherapy-induced resistance by ATP-binding cassette transporter genes,” Biochimica et Biophysica Acta - Reviews on Cancer. 2007, doi: 10.1016/j.bbcan.2007.05.002.

American Cancer Society, “Global Cancer Facts and Figures 2007,” Cancer, 2007.

R. Vijayakumar, C. Muthukumar, N. Thajuddin, A. Panneerselvam, and R. Saravanamuthu, “Studies on the diversity of actinomycetes in the Palk Strait region of Bay of Bengal, India,” Actinomycetologica, 2007, doi: 10.3209/saj.saj210203.

S. Ravikumar, M. Fredimoses, and M. Gnanadesigan, “Anticancer property of sediment actinomycetes against MCF-7 and MDA-MB-231 cell lines,” Asian Pac. J. Trop. Biomed., 2012, doi: 10.1016/S2221-1691(11)60199-8.

K. Stritzke, S. Schulz, H. Laatsch, E. Helmke, and W. Beil, “Novel Caprolactones from a Marine Streptomycete,” J. Nat. Prod., 2004, doi: 10.1021/np030321z.

F. Li et al., “Chinikomycins A and B: Isolation, structure elucidation, and biological activity of novel antibiotics from a marine Streptomyces sp. isolate M045,” J. Nat. Prod., 2005, doi: 10.1021/np030518r.

H. C. Kwon, C. A. Kauffman, P. R. Jensen, and W. Fenical, “Marinomycins A-D, antitumor-antibiotics of a new structure class from a marine actinomycete of the recently discovered genus ‘Marinispora,’” J. Am. Chem. Soc., 2006, doi: 10.1021/ja0558948.

T. Kawahara et al., “JBIR-94 and JBIR-125, antioxidative phenolic compounds from streptomyces sp. R56-07,” J. Nat. Prod., 2012, doi: 10.1021/np200734p.

L. T. H. Tan, H. L. Ser, W. F. Yin, K. G. Chan, L. H. Lee, and B. H. Goh, “Investigation of antioxidative and anticancer potentials of Streptomyces sp. MUM256 isolated from Malaysia mangrove soil,” Front. Microbiol., 2015, doi: 10.3389/fmicb.2015.01316.

Y. C. Ji, C. K. Hak, P. G. Williams, C. A. Kauffman, P. R. Jensen, and W. Fenical, “Actinofuranones A and B, polyketides from a marine-derived bacterium related to the genus Streptomyces (actinomycetales),” J. Nat. Prod., 2006, doi: 10.1021/np050402q.

D. C. Oh, E. A. Gontang, C. A. Kauffman, P. R. Jensen, and W. Fenical, “Salinipyrones and pacificanones, mixed-precursor polyketides from the marine actinomycete Salinispora pacifica,” J. Nat. Prod., 2008, doi: 10.1021/np0705155.

P. Manivasagan, S. Gnanam, K. Sivakumar, and T. Thangaradjou, “Antimicrobial and cytotoxic activities of an actinobacteria ( Streptomyces Sp . PM-32 ) isolated from an offshore sediments of the Bay of Bengal in Tamilnadu,” Adv. Biol. Res. (Rennes)., 2009.

V. R. R. K. Dasari, M. K. K. Muthyala, M. Y. Nikku, and S. R. R. Donthireddy, “Novel Pyridinium compound from marine actinomycete, Amycolatopsis alba var. nov. DVR D4 showing antimicrobial and cytotoxic activities in vitro,” Microbiol. Res., 2012, doi: 10.1016/j.micres.2011.12.003.

R. W. Pinner et al., “Trends in infectious diseases mortality in the United States,” JAMA, 1996, doi: 10.1001/jama.275.3.189.

P. Daszak, A. A. Cunningham, and A. D. Hyatt, “Emerging infectious diseases of wildlife - Threats to biodiversity and human health,” Science. 2000, doi: 10.1126/science.287.5452.443.

D. M. Morens, G. K. Folkers, and A. S. Fauci, “The challenge of emerging and re-emerging infectious diseases,” Nature. 2004, doi: 10.1038/nature02759.

K. E. Jones et al., “Global trends in emerging infectious diseases,” Nature, 2008, doi: 10.1038/nature06536.

M. E. J. Woolhouse, “Epidemiology: Emerging diseases go global,” Nature. 2008, doi: 10.1038/451898a.

B. S. Moore, J. A. Trischman, D. Seng, D. Kho, P. R. Jensen, and W. Fenical, “Salinamides, antiinflammatory depsipeptides from a marine streptomycete,” J. Org. Chem., 1999, doi: 10.1021/jo9814391.

S. L. Croft and G. H. Coombs, “Leishmaniasis - Current chemotherapy and recent advances in the search for novel drugs,” Trends in Parasitology. 2003, doi: 10.1016/j.pt.2003.09.008.

S. M. Pimentel-Elardo, S. Kozytska, T. S. Bugni, C. M. Ireland, H. Moll, and U. Hentschel, “Anti-parasitic compounds from Streptomyces sp. strains isolated from Mediterranean sponges,” Mar. Drugs, vol. 8, no. 2, pp. 373–380, 2010, doi: 10.3390/md8020373.

J. M. Reynolds, K. El Bissati, J. Brandenburg, A. Günzl, and C. Ben Mamoun, “Antimalarial activity of the anticancer and proteasome inhibitor bortezomib and its analog ZL3B,” BMC Clin. Pharmacol., 2007, doi: 10.1186/1472-6904-7-13.

S. S. Kumar, R. Philip, and C. T. Achuthankutty, “Antiviral property of marine actinomycetes against White Spot Syndrome Virus in penaeid shrimps,” Curr. Sci., 2006.

J. G. Lee, I. D. Yoo, and W. G. Kim, “Differential antiviral activity of benzastatin C and its dechlorinated derivative from Streptomyces nitrosporeus,” Biol. Pharm. Bull., 2007, doi: 10.1248/bpb.30.795.

M. Valko, D. Leibfritz, J. Moncol, M. T. D. Cronin, M. Mazur, and J. Telser, “Free radicals and antioxidants in normal physiological functions and human disease,” International Journal of Biochemistry and Cell Biology. 2007, doi: 10.1016/j.biocel.2006.07.001.

A. K. Tiwari, “Imbalance in antioxidant defence and human diseases: Multiple approach of natural antioxidants therapy,” Curr. Sci., 2001.

K. Kannabiran and M. Thenmozhi, “Studies on Isolation, Classification and Phylogenetic Characterization of Novel Antifungal Streptomyces sp. VITSTK7 in India,” Curr. Res. J. Biol. Sci., 2010.

A. Janardhan, A. P. Kumar, B. Viswanath, D. V. R. Saigopal, and G. Narasimha, “Production of Bioactive Compounds by Actinomycetes and Their Antioxidant Properties,” Biotechnol. Res. Int., 2014, doi: 10.1155/2014/217030.

N. Jaivel, C. Uvarani, R. Rajesh, D. Velmurugan, and P. Marimuthu, “Natural occurrence of organofluorine and other constituents from streptomyces sp. TC1,” J. Nat. Prod., 2014, doi: 10.1021/np400360h.

K. V. Raghava Rao and T. Raghava Rao, “Molecular characterization and its antioxidant activity of a newly isolated Streptomyces coelicoflavus BC 01 from mangrove soil,” J. Young Pharm., 2013, doi: 10.1016/j.jyp.2013.10.002.

D. R. Lee et al., “Antioxidant activity and free radical scavenging activities of Streptomyces sp. strain MJM 10778,” Asian Pac. J. Trop. Med., 2014, doi: 10.1016/S1995-7645(14)60170-X.




DOI: https://doi.org/10.24815/jocarbazon.v2i2.42883

Article Metrics

Abstract view : 0 times
PDF - 0 times

Refbacks

  • There are currently no refbacks.


Copyright (c) 2024 Journal of Carbazon

E-ISSN: 2988-5744

 

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).